ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,580,722 | +1.2% | 4,351,613 | +4.3% | 0.00% | 0.0% |
| Q2 2023 | $15,398,250 | +15.0% | 4,172,966 | +3.1% | 0.00% | 0.0% |
| Q1 2023 | $13,393,093 | +101826.1% | 4,046,250 | +19.5% | 0.00% | 0.0% |
| Q4 2022 | $13,140 | -99.8% | 3,386,852 | +3.1% | 0.00% | +100.0% |
| Q3 2022 | $7,985,000 | +26.3% | 3,286,129 | +2.9% | 0.00% | 0.0% |
| Q2 2022 | $6,320,000 | +101.0% | 3,192,128 | +85.8% | 0.00% | – |
| Q1 2022 | $3,144,000 | +57.8% | 1,718,079 | +21.5% | 0.00% | – |
| Q4 2021 | $1,993,000 | +34.4% | 1,413,525 | +7.6% | 0.00% | – |
| Q3 2021 | $1,483,000 | -12.0% | 1,313,094 | +24.7% | 0.00% | – |
| Q2 2021 | $1,685,000 | -29.5% | 1,053,327 | -22.4% | 0.00% | – |
| Q1 2021 | $2,390,000 | +21.5% | 1,358,149 | +34.6% | 0.00% | – |
| Q4 2020 | $1,967,000 | -15.9% | 1,008,737 | +3.0% | 0.00% | – |
| Q3 2020 | $2,340,000 | -26.6% | 979,145 | -10.1% | 0.00% | -100.0% |
| Q2 2020 | $3,190,000 | -2.3% | 1,088,995 | -4.0% | 0.00% | 0.0% |
| Q1 2020 | $3,265,000 | -43.0% | 1,133,984 | -20.9% | 0.00% | 0.0% |
| Q4 2019 | $5,732,000 | +106.9% | 1,433,216 | +130.2% | 0.00% | 0.0% |
| Q3 2019 | $2,770,000 | +63.6% | 622,494 | +42.3% | 0.00% | – |
| Q2 2019 | $1,693,000 | +38.7% | 437,560 | +35.8% | 0.00% | – |
| Q1 2019 | $1,221,000 | -7.6% | 322,183 | -41.8% | 0.00% | – |
| Q4 2018 | $1,322,000 | -12.0% | 553,860 | +128.8% | 0.00% | – |
| Q3 2018 | $1,503,000 | +65.7% | 242,112 | +20.4% | 0.00% | – |
| Q2 2018 | $907,000 | +76.1% | 201,110 | +79.6% | 0.00% | – |
| Q1 2018 | $515,000 | +43.5% | 112,000 | 0.0% | 0.00% | – |
| Q4 2017 | $359,000 | +443.9% | 112,000 | +420.3% | 0.00% | – |
| Q3 2017 | $66,000 | -19.5% | 21,526 | 0.0% | 0.00% | – |
| Q2 2017 | $82,000 | -28.1% | 21,526 | -8.6% | 0.00% | – |
| Q1 2017 | $114,000 | -4.2% | 23,558 | +1.2% | 0.00% | – |
| Q4 2016 | $119,000 | -28.7% | 23,282 | +0.8% | 0.00% | – |
| Q3 2016 | $167,000 | – | 23,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |